These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Different vascular endothelial growth factor (VEGF), VEGF-receptor 1 and -2 mRNA expression profiles between clear cell and papillary renal cell carcinoma. Ljungberg BJ; Jacobsen J; Rudolfsson SH; Lindh G; Grankvist K; Rasmuson T BJU Int; 2006 Sep; 98(3):661-7. PubMed ID: 16925769 [TBL] [Abstract][Full Text] [Related]
4. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma. Yao DF; Wu XH; Zhu Y; Shi GS; Dong ZZ; Yao DB; Wu W; Qiu LW; Meng XY Hepatobiliary Pancreat Dis Int; 2005 May; 4(2):220-6. PubMed ID: 15908319 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the expression of Ki-67, CD44 and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. Yildiz E; Gokce G; Kilicarslan H; Ayan S; Goze OF; Gultekin EY BJU Int; 2004 May; 93(7):1087-93. PubMed ID: 15142169 [TBL] [Abstract][Full Text] [Related]
7. VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma. Rivet J; Mourah S; Murata H; Mounier N; Pisonero H; Mongiat-Artus P; Teillac P; Calvo F; Janin A; Dosquet C Cancer; 2008 Jan; 112(2):433-42. PubMed ID: 18041056 [TBL] [Abstract][Full Text] [Related]
8. Angiogenesis in renal cell carcinoma: the role of tumor-associated macrophages. Toge H; Inagaki T; Kojimoto Y; Shinka T; Hara I Int J Urol; 2009 Oct; 16(10):801-7. PubMed ID: 19811548 [TBL] [Abstract][Full Text] [Related]
9. NF-KappaB expression correlates with apoptosis and angiogenesis in clear cell renal cell carcinoma tissues. Meteoglu I; Erdogdu IH; Meydan N; Erkus M; Barutca S J Exp Clin Cancer Res; 2008 Oct; 27(1):53. PubMed ID: 18928570 [TBL] [Abstract][Full Text] [Related]
10. [Expression of COX-2 and VEGF and their correlation with angiogenesis in human clear cell renal cell carcinoma]. Chang BD; Cao LS; Zhou HL Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):687-90. PubMed ID: 20021866 [TBL] [Abstract][Full Text] [Related]
11. Quantitative correlation of serum levels and tumor expression of vascular endothelial growth factor in patients with hepatocellular carcinoma. Poon RT; Lau CP; Cheung ST; Yu WC; Fan ST Cancer Res; 2003 Jun; 63(12):3121-6. PubMed ID: 12810638 [TBL] [Abstract][Full Text] [Related]
12. CD147 and VEGF expression in advanced renal cell carcinoma and their prognostic value. Liang YX; He HC; Han ZD; Bi XC; Dai QS; Ye YK; Qin WJ; Zeng GH; Zhu G; Xu CL; Zhong WD Cancer Invest; 2009 Aug; 27(7):788-93. PubMed ID: 19548138 [TBL] [Abstract][Full Text] [Related]
13. The relationship of vascular endothelial growth factor and coagulation factor (fibrin and fibrinogen) expression in clear cell renal cell carcinoma. Verheul HM; van Erp K; Homs MY; Yoon GS; van der Groep P; Rogers C; Hansel DE; Netto GJ; Pili R Urology; 2010 Mar; 75(3):608-14. PubMed ID: 19683801 [TBL] [Abstract][Full Text] [Related]
14. CXCR3-B expression correlates with tumor necrosis extension in renal cell carcinoma. Gacci M; Serni S; Lapini A; Vittori G; Alessandrini M; Nesi G; Palli D; Carini M J Urol; 2009 Feb; 181(2):843-8. PubMed ID: 19095263 [TBL] [Abstract][Full Text] [Related]
15. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma. Feldman AL; Alexander HR; Yang JC; Linehan WM; Eyler RA; Miller MS; Steinberg SM; Libutti SK Cancer; 2002 Oct; 95(8):1637-43. PubMed ID: 12365010 [TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor-A and vascular endothelial growth factor-C as prognostic factors for non-small cell lung cancer. Nakashima T; Huang CL; Liu D; Kameyama K; Masuya D; Ueno M; Haba R; Yokomise H Med Sci Monit; 2004 Jun; 10(6):BR157-65. PubMed ID: 15173661 [TBL] [Abstract][Full Text] [Related]
17. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. Baldewijns MM; Thijssen VL; Van den Eynden GG; Van Laere SJ; Bluekens AM; Roskams T; van Poppel H; De Bruïne AP; Griffioen AW; Vermeulen PB Br J Cancer; 2007 Jun; 96(12):1888-95. PubMed ID: 17505508 [TBL] [Abstract][Full Text] [Related]
18. Osteopontin expression correlates with prognostic variables and survival in clear cell renal cell carcinoma. Matusan K; Dordevic G; Stipic D; Mozetic V; Lucin K J Surg Oncol; 2006 Sep; 94(4):325-31. PubMed ID: 16917865 [TBL] [Abstract][Full Text] [Related]
19. Lymphangiogenesis in kidney cancer: expression of VEGF-C, VEGF-D and VEGFR-3 in clear cell and papillary renal cell carcinoma. Bierer S; Herrmann E; Köpke T; Neumann J; Eltze E; Hertle L; Wülfing C Oncol Rep; 2008 Oct; 20(4):721-5. PubMed ID: 18813809 [TBL] [Abstract][Full Text] [Related]
20. Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry. Iwata T; Miyata Y; Kanda S; Nishikido M; Hayashi T; Sakai H; Kanetake H Urology; 2008 Apr; 71(4):749-54. PubMed ID: 18295862 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]